CTRI/2023/08/056584招募中4 期
Comparison of Effectiveness and Safety of Imeglimin and Metformin monotherapy in type 2 Diabetes Mellitus: A Randomised Open Label Parallel Group Phase IV Controlled Trial - Nil
Other Self0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Newly Diagnosed cases with Type 2 Diabetes Mellitus
- •HbA1c >7.5% and <9%
排除标准
- •Female patient who are pregnant and lactating
- •Patients on any other glucose lowering agent
- •Establised Cardiovascular disease, Compromised renal Function(eGFR <60) AND Liver function (enzymes >3 ULN) and psychiatric illness
研究者
相似试验
招募中
Unknown
Evaluation of the efficiency and safety of imeglimin on insulin secretion ability and insulin sensitivity in the treatment of type 2 diabetes mellitustype 2 diabetesJPRN-UMIN000053150Department of Diabetes and Metabolism,Tohto Clinic30
尚未招募
4 期
Efficacy of drug Ondansetron for prevention of low blood pressure (hypotension)CTRI/2024/04/066242one
招募中
4 期
COMPARISON OF METFORMIN AND GLIMEPIRIDE IN PATIENTS OF COEXISTING TYPE 2 DIABETES MELLITUS AND NON ALCOHOLIC FATTY LIVER DISEASECTRI/2019/06/019926nil
招募中
不适用
Comparision of the benefits and harm of indacaterol acetate and glycopyronium bromide with salmetrol and fluticasone in bronchial asthma patients.CTRI/2018/05/014079Aligarh Muslim University
招募中
不适用
The study on the efficacy and safety of combination of low dose propiverine hydrocholoride and alpha-antagonist in men with BPH with overactive bladderDiseases of The genitoruinary systemKCT0000077Inha University Hospital236